bestshares.com Logo
Popular
  • NVDA
    NVDA Nvidia
  • GOOGL
    GOOGL Alphabet Inc.
  • AAPL
    AAPL Apple Inc.
  • MSFT
    MSFT Microsoft Corporation
  • AMZN
    AMZN Amazon.com, Inc.
  • SPY
    SPY SPDR S&P 500 ETF Trust
  • QQQ
    QQQ Invesco QQQ Trust
    • Monte Rosa Therapeutics Inc. logo

    Monte Rosa Therapeutics Inc.

    GLUE | NASDAQ
    Chart Builder DCF Calculator
    $12.26
    +$0.13 (+1.07%)
    At close: Sep 21, 2026, 4:00 PM ET
    $12.34
    +$0.08 (+0.65%)
    Pre-market: Sep 22, 2026, 5:22 AM ET
    Overview Rating Statistics Financials Earnings Analysts Ownership Profile

    Market Data

    Market Cap
    $1.02B
    Enterprise Value
    $452.6M
    Beta
    1.50
    Average Volume
    1.24M
    Shares Outstanding (Diluted)
    101.48M
    Shares Change YoY
    23.47%
    Institutional Ownership
    N/A
    Exchange
    NASDAQ
    ISIN
    US61225M1027

    Price Performance

    Price Change 1M
    -13.4%
    Price Change 3M
    -40.8%
    Price Change 6M
    -22.0%
    Price Change YTD
    -19.9%
    Price Change 1Y
    87.8%
    Price Change 3Y
    104.3%
    Price Change 5Y
    -48.7%
    1M CAGR (ann.)
    -22.8%
    1Y CAGR (ann.)
    90.7%
    5Y CAGR (ann.)
    -19.1%
    All-Time CAGR
    -10.1%

    Valuation

    PE Ratio
    -5.73
    Forward PE
    N/A
    PEG Ratio
    0.68
    Forward PEG
    -0.21
    PS Ratio
    36.05
    Forward PS
    18.10
    PB Ratio
    2.13
    P/FCF Ratio
    -14.52
    P/Adj. FCF Ratio
    -10.58
    P/OCF Ratio
    -17.03
    EV/Sales
    15.76
    EV/EBIT
    -2.76
    EV/EBITDA
    -2.90
    EV/FCF
    -6.35
    Earnings Yield
    -17.5%
    FCF Yield
    -6.9%
    Adj. FCF Yield
    -9.4%

    Financial Health

    Net Cash
    $583.12M
    Total Debt
    $37.99M
    Cash & Short-Term Investments
    $621.1M
    Total Assets
    $696.08M
    Current Ratio
    9.52
    Quick Ratio
    9.52
    Debt / Equity Ratio
    0.08
    Debt / EBITDA
    -0.24
    Debt / FCF
    -0.53
    OCF / Debt
    -1.62
    Interest Coverage
    0.00
    Altman Z-Score
    2.02
    Piotroski F-Score
    2

    Margins & Profitability

    Gross Profit Margin
    92.9%
    Operating Profit Margin
    -633.0%
    EBITDA Margin
    -542.5%
    Net Profit Margin
    -560.9%
    FCF Margin
    -248.3%
    Adj. FCF Margin
    -340.6%
    SBC / Revenue
    92.4%
    SBC Impact (per share)
    -37.2%

    Returns

    Return on Assets
    -23.1%
    Return on Equity
    -43.3%
    Return on Invested Capital
    -28.2%
    Return on Capital Employed
    -28.9%
    Return on Tangible Assets
    -23.1%

    Historical Growth (CAGR)

    Revenue CAGR 3Y
    16.2%
    Revenue CAGR 5Y
    55.4%
    Revenue CAGR 10Y
    N/A
    EPS CAGR 3Y
    3.7%
    EPS CAGR 5Y
    14.9%
    EPS CAGR 10Y
    N/A
    FCF CAGR 3Y
    -4.6%
    FCF CAGR 5Y
    27.4%
    FCF CAGR 10Y
    N/A

    Analyst Forecasts

    Analyst Rating
    Buy
    Analyst Count
    9
    EPS Growth Next 3Y
    0.8%
    Revenue Growth Next 3Y
    62.6%
    Earnings Date
    N/A
    EPS Estimate (next Q)
    N/A
    EPS Growth Est (next Q)
    N/A
    Revenue Est (next Q)
    N/A
    Revenue Growth Est (next Q)
    N/A

    Fair Value Estimates

    Graham Number
    N/A
    Graham Upside
    N/A
    Lynch Fair Value
    N/A
    Lynch Upside
    N/A
    Price Target
    $26.67
    Price Target Upside
    117.5%

    Cash Flow

    Operating Cash Flow
    $-61.44M
    Free Cash Flow
    $-71.32M
    Adj. Free Cash Flow
    $-97.86M
    FCF Per Share
    -$0.84
    OCF Per Share
    -$0.72
    OCF/S Ratio
    -213.9%

    Income Statement

    Revenue
    $28.73M
    Gross Profit
    $26.7M
    Operating Income
    $-181.85M
    EBITDA
    $-155.85M
    Net Income
    $-161.12M
    EPS (Diluted)
    -$2.14
    Revenue / Employee
    $166.05K
    Profit / Employee
    $-931.31K
    Employees
    173

    © 2026 bestshares.com. All rights reserved.